about
Plasmid-mediated quinolone resistance: a multifaceted threatAntimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).Imaging bacteria with radiolabelled quinolones, cephalosporins and siderophores for imaging infection: a systematic reviewSOS response and its regulation on the fluoroquinolone resistance.The Three Bacterial Lines of Defense against Antimicrobial AgentsMechanistic and Structural Analysis of Aminoglycoside N -Acetyltransferase AAC(6′)-Ib and Its Bifunctional, Fluoroquinolone-Active AAC(6′)-Ib-cr Variant † ‡The structure of LpxD fromPseudomonas aeruginosaat 1.3 Å resolutionClinical management of infections caused by multidrug-resistant EnterobacteriaceaeThe pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencingPlasmid-mediated quinolone resistance in Enterobacteriaceae: a systematic review with a focus on Mediterranean countries.Population structure of Japanese extraintestinal pathogenic Escherichia coli and its relationship with antimicrobial resistance.A novel high-throughput cell-based assay aimed at identifying inhibitors of DNA metabolism in bacteriaPredicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data.Impact of minimal inhibitory concentration breakpoints on local cumulative bacterial susceptibility data and antibiotic consumptionGenome-scale identification method applied to find cryptic aminoglycoside resistance genes in Pseudomonas aeruginosa.Repression of invasion genes and decreased invasion in a high-level fluoroquinolone-resistant Salmonella typhimurium mutant.Increasing Resistance to Extended-Spectrum Cephalosporins, Fluoroquinolone, and Carbapenem in Gram-Negative Bacilli and the Emergence of Carbapenem Non-Susceptibility in Klebsiella pneumoniae: Analysis of Korean Antimicrobial Resistance Monitoring SIncreased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location.Fluoroquinolone resistance during 2000-2005: an observational study.Prevalence of plasmid-mediated quinolone resistance in Escherichia coli isolated from diseased animals in Taiwan.Emergence of resistant salmonella spp.; new challenges, new trendsCurrent Advances in Developing Inhibitors of Bacterial Multidrug Efflux PumpsRecommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014The prevalence of gene duplications and their ancient origin in Rhodobacter sphaeroides 2.4.1.High levels of multiresistance in quinolone resistant urinary tract isolates of Escherichia coli from Norway; a non clonal phenomen?Semimechanistic pharmacokinetic-pharmacodynamic model with adaptation development for time-kill experiments of ciprofloxacin against Pseudomonas aeruginosa.RecA maintains the integrity of chloroplast DNA molecules in ArabidopsisGastrointestinal tract colonization with fluoroquinolone-resistant Escherichia coli in hospitalized patients: changes over time in risk factors for resistance.Discovery research: the scientific challenge of finding new antibiotics.Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.Emergence of quinolone resistance among extended-spectrum beta-lactamase-producing Enterobacteriaceae in the Central African Republic: genetic characterization.Plasmidic qnrA3 enhances Escherichia coli fitness in absence of antibiotic exposure.Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England.Isolation of Escherichia coli strains with AcrAB-TolC efflux pump-associated intermediate interpretation or resistance to fluoroquinolone, chloramphenicol and aminopenicillin from dogs admitted to a university veterinary hospitalIn vitro synergism of ciprofloxacin and cefotaxime against nalidixic acid-resistant Salmonella enterica serotypes Paratyphi A and Paratyphi B.Quinolones: from antibiotics to autoinducers.New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.Repurposing the antihistamine terfenadine for antimicrobial activity against Staphylococcus aureus.Alternating antibiotic treatments constrain evolutionary paths to multidrug resistanceSequence-specific antimicrobials using efficiently delivered RNA-guided nucleases.
P2860
Q24645356-1ADEEF76-B95E-4169-A461-4F750B009B01Q26739860-6B05B506-F8B0-4A28-B35E-536620685D06Q26741887-0AFE2C8F-DD62-4267-8C39-DDA25315D784Q26774868-3AC40806-81A1-433D-BA17-5485BA0FB372Q26786956-A8233A68-91DC-4CB9-BCAC-5C50FDF8D8E3Q27651667-B75A29C1-9685-4F0D-AB14-AA3D38D29055Q27671074-54074E4E-87E2-419E-AF2F-ED2A8A1D75DCQ28246841-48D586D7-82D2-4FD2-A01C-0D4118770703Q29615054-4A294055-25EA-429E-8ED0-95850F907E18Q30240591-A37B4CC1-EABB-4C21-B5F3-BBB336F8C9D4Q30397339-2CF2E10A-5689-4B7F-A3D6-C136D7FCAB0BQ30410098-7106F293-4213-4D22-A739-A692B09BF369Q30636622-3E3D04AB-4B48-403D-BE1F-D7C0957263A0Q30847357-AA7A30AE-A231-4510-B82B-FF0D3BC3E943Q30882914-3A1261CC-EEC8-4AFF-A1AE-D03B00C88DF6Q30928036-55754005-E133-4023-8B6F-C8CA55D97806Q31164789-871B5D03-8E80-45EF-A81B-6D69D0FA6523Q33314977-1C274FC1-8C71-4401-8C8B-BDF01C26E3BDQ33337504-E69A036C-0008-43EA-BE03-18FB9BEA0EEAQ33593983-9FA16EAC-B4A7-4A43-AA6E-1BD1171903B4Q33596311-DC12DEB7-7FA5-45DA-AE22-BEDA18ABC004Q33659230-88B35C6B-8736-4236-A3B3-FAA196162DF9Q33720510-AE2C0713-F1BC-4793-AADD-4EF086190839Q33782378-FF736C24-3EBF-4617-83DD-D6612A2D710FQ33831154-70AFD172-4D32-442F-B5AF-4F0B4D6D9632Q33876563-A4FD1D04-B9C2-43A4-990B-58BA8E561766Q33900056-F949445C-E36B-4702-A539-6D2FD9C55731Q33905604-43055CA9-D179-4DF0-8DAC-114F2B25F2C3Q33941796-8556AC51-9EE6-420E-8734-F289021CB5F5Q33945413-607AEAF1-1A6B-4991-B872-DECEEB72D4EAQ34002799-17531D3A-7F45-48CC-A377-E2BB22581004Q34019104-81A5DC1B-002E-418F-82C9-D797C50E4F00Q34057927-62904606-24F6-4F69-B522-96F9E981073CQ34085440-6C818703-C3DE-4269-A314-0F7A97D4A74CQ34108754-75475C67-B231-4395-BEC8-22ABBD2A6E3FQ34133116-97A8C643-F6F9-49FF-82BF-B0D7D4B8D062Q34143901-D311B34C-44FB-4B40-8675-606F9BF5AB31Q34394167-507F71EE-A066-4C80-ABE3-224B8AE948DCQ34407557-36CCDAD3-98EF-46B3-BBD8-A7AE3C4799E4Q34439737-2624B3FB-01F0-46D2-8272-90FB5BCF216E
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Mechanisms of resistance to quinolones.
@ast
Mechanisms of resistance to quinolones.
@en
type
label
Mechanisms of resistance to quinolones.
@ast
Mechanisms of resistance to quinolones.
@en
prefLabel
Mechanisms of resistance to quinolones.
@ast
Mechanisms of resistance to quinolones.
@en
P2860
P356
P1476
Mechanisms of resistance to quinolones.
@en
P2093
George A Jacoby
P2860
P304
P356
10.1086/428052
P407
P478
41 Suppl 2
P577
2005-07-01T00:00:00Z